A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)
Study sponsor: Corcept Therapeutics
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-07-29Actual
Enrollment · participants150Actual
Source updated2024-06-13Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.